GLP-1s like Ozempic, Wegovy, Semaglutide, Mounjaro, Zepbound, Tirzepatide, Liraglutide, Saxenda, Trulicity, and Victoza introduce a unique interplay that heightens the risk of dehydration through various mechanisms: Enhanced urinary output: GLP-1 therapy often amplifies urinary frequency as a consequence of its blood sugar-lowering effects
What happens in your mouth doesnt stay there
Alteration in insulin signaling may accelerate the onset of Alzheimers disease, by changing the intracellular concentration of neurotransmitters involved in memory formation and functioning, and influencing on amyloid--related processes and amyloid clearance (Spinelli et al., 2019
For a 200 mcg dose: 200 / 3,333 = 0.06 mL = 6 units on a U-100 syringe
Toward a molecular neuropsychiatry of neurodegenerative diseases